AU6454096A - Use of neuronal calcium channel blockers for the manufacture of a medicament for the treatment of psychoses, schizophrenia and cocaine or amphetamine addiction - Google Patents

Use of neuronal calcium channel blockers for the manufacture of a medicament for the treatment of psychoses, schizophrenia and cocaine or amphetamine addiction

Info

Publication number
AU6454096A
AU6454096A AU64540/96A AU6454096A AU6454096A AU 6454096 A AU6454096 A AU 6454096A AU 64540/96 A AU64540/96 A AU 64540/96A AU 6454096 A AU6454096 A AU 6454096A AU 6454096 A AU6454096 A AU 6454096A
Authority
AU
Australia
Prior art keywords
psychoses
cocaine
schizophrenia
medicament
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64540/96A
Inventor
Thomas Gary Heffner
Michael Francis Rafferty
James Nicholson Wiley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of AU6454096A publication Critical patent/AU6454096A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU64540/96A 1995-07-26 1996-07-08 Use of neuronal calcium channel blockers for the manufacture of a medicament for the treatment of psychoses, schizophrenia and cocaine or amphetamine addiction Abandoned AU6454096A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US151895P 1995-07-26 1995-07-26
US001518 1995-07-26
PCT/US1996/011365 WO1997004797A1 (en) 1995-07-26 1996-07-08 Use of neuronal calcium channel blockers for the manufacture of a medicament for the treatment of psychoses, schizophrenia and cocaine or amphetamine addiction

Publications (1)

Publication Number Publication Date
AU6454096A true AU6454096A (en) 1997-02-26

Family

ID=21696445

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64540/96A Abandoned AU6454096A (en) 1995-07-26 1996-07-08 Use of neuronal calcium channel blockers for the manufacture of a medicament for the treatment of psychoses, schizophrenia and cocaine or amphetamine addiction

Country Status (2)

Country Link
AU (1) AU6454096A (en)
WO (1) WO1997004797A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020022748A (en) * 2002-03-07 2002-03-27 동성 김 Synthesis of Polyacrylic high absorbent polymer with Transparency

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG50624A1 (en) * 1991-12-30 1998-07-20 Neurex Corp Methods of producing analgesia and enhancing opiate analgesia
GB9324871D0 (en) * 1993-12-03 1994-01-19 Lilly Industries Ltd Novel compounds

Also Published As

Publication number Publication date
WO1997004797A1 (en) 1997-02-13

Similar Documents

Publication Publication Date Title
HK1008180A1 (en) Use of vitamin d 2 or vitamin d 4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism
GB2297259B (en) Epidural catheter
AU7250294A (en) Treatment of multidrug resistant diseases
GB9711451D0 (en) A process for the treatment of effluent streams
AU1238895A (en) The use of benzazoles as UV absorbers, new benzazoles and a process for their preparation
EP0792172A4 (en) Identification ring for catheter
AU1266895A (en) Process for making laxatives containing dioctyl sulfosuccinate
AU7757994A (en) Process for manufacturing surgical needles
AU5802196A (en) Use of bis-1,2,4-triazoles for the manufacture of a medicament for the treatment of cancers
AU3326297A (en) A process for producing inorganic granules and the use thereof
AU4517893A (en) An oral formulation for gastric antibacterial treatment as well as a process thereof and the use
AU4840799A (en) Disposable treatment article having a responsive system
EP0400665A3 (en) Use of a calcium channel blocker for preventing or treating anxiety
AU1116895A (en) Use of theophylline for the manufacture of a medicament for the treatment of asthma
AU6454096A (en) Use of neuronal calcium channel blockers for the manufacture of a medicament for the treatment of psychoses, schizophrenia and cocaine or amphetamine addiction
AU3989395A (en) Safety glove
HUP9800334A3 (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity
AU4844796A (en) A prolonged release composition, use and production thereof
IL129858A (en) Use of polyether-based plastics for the production of safety clothing
GB2303303B (en) Medical treatment
GB9521725D0 (en) Medical treatment
AU7726796A (en) Use of 3-oxa-d-prostaglandins for the manufacture of a medicament for the treatment of glaucoma
HUP9802076A3 (en) Novel n-oxides as antibacterial agents, their production and medicaments thereof
GB9526264D0 (en) Medical treatment
AU3874795A (en) Oral treatment